We set out to determine the average mRNA expression of FGFR1, leptin, and LepR in normal breast tissue and breast cancer tissue using publicly available genomic datasets including The Cancer Genome Atlas (TCGA), Tumor Alterations Relevant for Genomics-driven Therapy (TARGET), the Genome-Tissue Expression project (GTEx), and Met500. This evidence concerns the gene FGFR1 and breast cancer.